Literature DB >> 22566090

A comparative study of the characteristics of two Coxsackie A virus type 16 strains (genotype B).

Erxia Yang1, Heng Zhao, Ying Zhang, Jiansheng Liu, Yun Liao, Lichun Wang, Pingfang Cui, Lixian Yang, Longding Liu, Chenghong Dong, Shaozhong Dong, Congwen Shao, Li Jiang, Le Sun, Qihan Li.   

Abstract

Coxsackie A virus is one of the major pathogens associated with hand, foot and mouth disease (HFMD). The etiological characteristics of Coxsackie A virus type 16 (CA16) are thought to correlate with the pathological process of its infection. Two CA16 strains that were isolated from a severe HFMD patient presented with different plaque forms. This observation, along with biological analysis, indicated that the differences in the strains' biological characteristics, such as proliferation kinetics and immunogenicity, correlate with differences in their pathogenicity toward neonatal mice. Furthermore, these differences are thought to be associated with the sequence of the 5' non-coding region of the viral genome and the VP1 structural region sequence. The results suggest that the biological and genetic characteristics of the CA16 viral strains are relevant to their pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22566090     DOI: 10.1007/s11427-012-4313-z

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  7 in total

Review 1.  Is a multivalent hand, foot, and mouth disease vaccine feasible?

Authors:  Michel Klein; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015-05-26       Impact factor: 3.452

2.  A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge.

Authors:  Ruixiao Du; Qunying Mao; Yalin Hu; Shuhui Lang; Shiyang Sun; Kelei Li; Fan Gao; Lianlian Bian; Ce Yang; Bopei Cui; Longfa Xu; Tong Cheng; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

3.  Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line.

Authors:  Erxia Yang; Chen Cheng; Ying Zhang; Jingjing Wang; Yanchun Che; Jing Pu; Chenghong Dong; Longding Liu; Zhanlong He; Shuaiyao Lu; Yuan Zhao; Li Jiang; Yun Liao; Congwen Shao; Qihan Li
Journal:  Hum Vaccin Immunother       Date:  2014-02-28       Impact factor: 3.452

Review 4.  Coxsackievirus A16: epidemiology, diagnosis, and vaccine.

Authors:  Qunying Mao; Yiping Wang; Xin Yao; Lianlian Bian; Xing Wu; Miao Xu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2013-11-14       Impact factor: 3.452

5.  Coxsackievirus A16 infection induces neural cell and non-neural cell apoptosis in vitro.

Authors:  Zhaolong Li; Jinghua Yu; Li Liu; Zhenhong Wei; Elana S Ehrlich; Guanchen Liu; Jingliang Li; Xin Liu; Hong Wang; Xiao-fang Yu; Wenyan Zhang
Journal:  PLoS One       Date:  2014-10-28       Impact factor: 3.240

6.  Isolation and characterization of dengue virus serotype 2 from the large dengue outbreak in Guangdong, China in 2014.

Authors:  Hui Zhao; LingZhai Zhao; Tao Jiang; XiaoFeng Li; Hang Fan; WenXin Hong; Yu Zhang; Qin Zhu; Qing Ye; YiGang Tong; WuChun Cao; FuChun Zhang; ChengFeng Qin
Journal:  Sci China Life Sci       Date:  2014-12-11       Impact factor: 6.038

7.  A novel 2006 Indian outbreak strain of Chikungunya virus exhibits different pattern of infection as compared to prototype strain.

Authors:  Abhishek Kumar; Prabhudutta Mamidi; Indrani Das; Tapas K Nayak; Sameer Kumar; Jagamohan Chhatai; Subhasis Chattopadhyay; Amol R Suryawanshi; Soma Chattopadhyay
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.